Facebook Linkedin Twitter
Inside Precision Medicine CureVac Announces Positive Phase II Data For mRNA Flu Vaccine

Influenza vaccine

Photo showing a patient having a flu vaccine injected into their arm by a healthcare professional (only the patient's shoulder and arm and the hands of the healthcare professional are visible)
Coronavirus

CureVac Announces Positive Phase II Data For mRNA Flu Vaccine

Helen Albert -
0
Leukaemia blood cells in CLL, SEM
News & Features

Danish Researchers Show Feasibility of Stopping Specialist Follow-Up in Low-Risk CLL patients

Chris Anderson -
0
IPM October 2022 cover
News & Features

Inside Precision Medicine Magazine Volume 9, Issue No. 5

Clinical OMICs Staff Writer -
0
William Haseltine
News & Features

The Pursuit of a Universal Influenza Vaccine

Kathy Vuksanaj -
0
Berg will use its Interrogative Biology® platform to identify potential biomarkers of Sanofi Pasteur seasonal influenza vaccine performance. [Source:
News & Features

Berg Partners with Sanofi Pasteur to Research Flu Vaccine Biomarkers

Clinical OMICs Staff Writer -
0

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine